| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Eleni Liapi | |
| Jean-Francois Geschwind | |||
| Riad Salem | |||
| Robert J Lewandowski | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Yttrium-90 microspheres: radiation therapy for unresectable liver cancer | Q28204605 | ||
| RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
| Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
| Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
| Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Q29617957 | ||
| Reporting results of cancer treatment | Q29620070 | ||
| Preoperative superselective arteriolar embolization: a new approach to enhance resectability of spinal tumors | Q30455503 | ||
| Pre-operative transarterial embolization for treatment of primary sacral tumors | Q33273861 | ||
| Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: a Phase II-study and historical comparison with the surgical approach | Q33282669 | ||
| Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver | Q33478466 | ||
| Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature | Q33502056 | ||
| Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study | Q33631372 | ||
| Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study | Q33691454 | ||
| Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma | Q34089023 | ||
| Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. | Q34168811 | ||
| TREATMENT OF INOPERABLE PRIMARY PANCREATIC AND LIVER CANCER BY THE INTRA-ARTERIAL ADMINISTRATION OF RADIOACTIVE ISOTOPES (Y90 RADIATING MICROSPHERES). | Q34260705 | ||
| Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead | Q46948670 | ||
| Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). | Q46966631 | ||
| Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report | Q47251794 | ||
| A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver | Q47575070 | ||
| A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. | Q50956760 | ||
| Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. | Q51082254 | ||
| Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. | Q51121731 | ||
| Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. | Q51129985 | ||
| Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma. | Q51147086 | ||
| Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. | Q51192472 | ||
| Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. | Q51204089 | ||
| New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. | Q51218640 | ||
| Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. | Q51300479 | ||
| Efficacy and safety of hepatic artery infusion catheter placement without fixation in the right gastroepiploic artery. | Q51514358 | ||
| Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. | Q51593250 | ||
| Ultrasound-Guided Radiological Placement of Central Venous Port via the Subclavian Vein: A Retrospective Analysis of 500 Cases at a Single Institute. | Q51774846 | ||
| Treatment of metastatic sarcoma to the liver with bland embolization. | Q51933953 | ||
| Pharmacologic rationale for regional drug delivery. | Q52694095 | ||
| Contrast-enhanced abdominal angiographic CT for intra-abdominal tumor embolization: a new tool for vessel and soft tissue visualization. | Q52925841 | ||
| Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | Q53263238 | ||
| Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. | Q53445890 | ||
| Effect of C-arm angiographic CT on transcatheter arterial chemoembolization of liver tumors. | Q53460936 | ||
| Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. | Q53513097 | ||
| Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis. | Q53558959 | ||
| The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. | Q53573559 | ||
| Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. | Q53592052 | ||
| Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. | Q53657792 | ||
| The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocol | Q53995684 | ||
| Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization | Q54615028 | ||
| Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo. | Q55038120 | ||
| Iodized oil in the treatment of hepatocellular carcinoma | Q34316492 | ||
| Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. | Q34377645 | ||
| DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. | Q34499773 | ||
| Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients | Q34569671 | ||
| Renal artery embolisation in the palliative treatment of renal carcinoma | Q34579411 | ||
| Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. | Q34581507 | ||
| Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis | Q34585175 | ||
| Intrahepatic arterial infusion of chemotherapy: pharmacologic principles | Q34598621 | ||
| Intrahepatic arterial infusion of combination of mitomycin-C and 5-fluorouracil in treatment of primary and metastatic liver carcinoma | Q34604829 | ||
| Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis | Q34621197 | ||
| A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial | Q34665442 | ||
| Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial | Q34683968 | ||
| A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases | Q34684005 | ||
| A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma | Q34721838 | ||
| Chemoembolization of hepatocellular carcinoma | Q34922680 | ||
| Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation | Q34982068 | ||
| Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes | Q35004090 | ||
| Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma | Q35051942 | ||
| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma | Q35085486 | ||
| Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug development and practice | Q35124313 | ||
| Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. | Q35322713 | ||
| Conformal chemoradiation for primary and metastatic liver malignancies. | Q35597404 | ||
| Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers | Q35979752 | ||
| Angiographic considerations in patients undergoing liver-directed therapy | Q36185940 | ||
| Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm. | Q36185946 | ||
| Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. | Q36441150 | ||
| Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. | Q36573194 | ||
| Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. | Q36631298 | ||
| Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer | Q36713156 | ||
| Radioembolization with 90Y microspheres: angiographic and technical considerations. | Q36827868 | ||
| Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma | Q36845140 | ||
| Transcatheter arterial chemoembolization: current technique and future promise. | Q36990903 | ||
| Technical aspects of radioembolization with 90Y microspheres. | Q36990908 | ||
| Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. | Q37023538 | ||
| Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. | Q37097717 | ||
| Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. | Q37113151 | ||
| Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study | Q37384240 | ||
| Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? | Q37808643 | ||
| Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy | Q38548003 | ||
| Treatment of carcinoid liver metastases by hepatic-artery embolisation | Q39472675 | ||
| Hybrid MR interventional imaging system: combined MR and angiography suites with single interactive table. Feasibility study in vascular liver tumor procedures | Q39604345 | ||
| Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. | Q39609899 | ||
| Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients | Q39749784 | ||
| Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies. | Q39824354 | ||
| A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil | Q39863354 | ||
| Doxorubicin-loaded QuadraSphere microspheres: plasma pharmacokinetics and intratumoral drug concentration in an animal model of liver cancer | Q39915670 | ||
| Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma | Q39926325 | ||
| Human liver cancer cells and endothelial cells incorporate iodised oil. | Q39989411 | ||
| Effect of transcatheter arterial embolization on levels of hypoxia-inducible factor-1alpha in rabbit VX2 liver tumors. | Q40134286 | ||
| Hepatic toxicity resulting from cancer treatment. | Q40505524 | ||
| Embolotherapy: agents, clinical applications, and techniques | Q40692454 | ||
| Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma | Q41627650 | ||
| Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model | Q41951820 | ||
| Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation | Q42601023 | ||
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | Q43010373 | ||
| Preoperative transcatheter arterial embolization of hypervascular metastatic tumors of long bones | Q43104694 | ||
| Targeted gene delivery to selected liver segments via isolated hepatic perfusion | Q43110397 | ||
| Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. | Q43419259 | ||
| Therapeutic Transcatheter Arterial Embolization | Q43677593 | ||
| Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer | Q43885252 | ||
| Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system | Q43908719 | ||
| Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial | Q43909975 | ||
| Renal artery embolization in the palliative treatment of renal adenocarcinoma | Q44168659 | ||
| Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy | Q44276712 | ||
| Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial | Q44306113 | ||
| Transcatheter oily chemoembolization of hepatocellular carcinoma | Q44371433 | ||
| Hepatic, arterial embolization in patients with malignant liver tumours (author's transl) | Q44471874 | ||
| Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres. | Q44764361 | ||
| Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines | Q44805162 | ||
| Hyperfractionated, accelerated radiotherapy and concurrent chemotherapy in locally advanced bladder cancer | Q44918136 | ||
| Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodized oil. | Q44929124 | ||
| Preparation and characterisation of poly(vinyl alcohol)/cyclodextrin microspheres as matrix for inclusion and separation of drugs. | Q45110116 | ||
| Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer | Q45119871 | ||
| Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma | Q45296442 | ||
| Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver. | Q45881031 | ||
| Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. | Q46014412 | ||
| Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma | Q46087308 | ||
| Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas | Q46464407 | ||
| Isolated limb infusion for advanced soft tissue sarcoma of the extremity. | Q46467699 | ||
| Outcomes following isolated limb infusion for melanoma. A 14-year experience | Q46569856 | ||
| Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. | Q55067548 | ||
| Particle embolization for hepatocellular carcinoma. | Q55068027 | ||
| Non-operative arterial embolisation in primary liver tumours | Q55282185 | ||
| Role of Kupffer cells in iodized oil embolization | Q57189860 | ||
| Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial | Q57763473 | ||
| Intraarterial Therapy with a New Potent Inhibitor of Tumor Metabolism (3-bromopyruvate): Identification of Therapeutic Dose and Method of Injection in an Animal Model of Liver Cancer | Q60531739 | ||
| Escalated Focal Liver Radiation and Concurrent Hepatic Artery Fluorodeoxyuridine for Unresectable Intrahepatic Malignancies | Q61771738 | ||
| Work in progress: transcatheter management of primary carcinoma of the liver | Q67270737 | ||
| Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer | Q67465233 | ||
| Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin | Q67491487 | ||
| Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial | Q68424140 | ||
| A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma | Q68488737 | ||
| Hepatic artery embolization in 120 patients with unresectable hepatoma | Q70150850 | ||
| The role of preoperative embolization in renal cell carcinoma | Q71303926 | ||
| Stimulation of tumor growth in vitro and in vivo by suramin on the VX2 model | Q71585383 | ||
| Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT) | Q72390308 | ||
| Roentgen-guided infarctions of kidneys and lungs. A potential therapeutic technic | Q72535456 | ||
| Hepatic artery embolization in 32 patients with unresectable hepatoma | Q72648254 | ||
| Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver | Q72689081 | ||
| In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors | Q72706522 | ||
| Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study | Q72709851 | ||
| Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up | Q72729791 | ||
| Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres | Q73093019 | ||
| Can current models explain the lack of liver complications in Y-90 microsphere therapy? | Q73131968 | ||
| Results of preoperative embolization for metastatic spinal neoplasms | Q73157322 | ||
| Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis | Q73250657 | ||
| Transarterial infusion of cisplatin and doxorubicin in bladder cancer | Q73317832 | ||
| Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from | Q73358680 | ||
| Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems | Q73634816 | ||
| Percutaneous implantation of a catheter with subcutaneous reservoir for intraarterial regional chemotherapy: technique and preliminary results | Q73815654 | ||
| The hepatic artery | Q74025631 | ||
| Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma | Q74093462 | ||
| RADIATION HEPATITIS | Q77134952 | ||
| Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization | Q77802566 | ||
| Chemoembolization of hepatocellular carcinoma with cisplatin, doxorubicin, mitomycin-C, ethiodol, and polyvinyl alcohol: prospective evaluation of response and survival in a U.S. population | Q77958407 | ||
| Chemoembolization of liver metastasis from breast carcinoma | Q79793493 | ||
| Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging | Q80736424 | ||
| Percutaneous femoral catheter placement for long-term chemotherapy infusions: preliminary technical results | Q81435159 | ||
| Percutaneous femoral implantation of an arterial port catheter for intraarterial chemotherapy: feasibility and predictive factors of long-term functionality | Q82208661 | ||
| A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization | Q84121312 | ||
| Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization | Q84620199 | ||
| Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study | Q84807162 | ||
| Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study | Q85026135 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 641-657 | |
| P577 | publication date | 2011-06-01 | |
| P1433 | published in | Radiology | Q3285690 |
| P1476 | title | Transcatheter intraarterial therapies: rationale and overview | |
| P478 | volume | 259 |
| Q37088693 | 3D Quantitative tumour burden analysis in patients with hepatocellular carcinoma before TACE: comparing single-lesion vs. multi-lesion imaging biomarkers as predictors of patient survival |
| Q36372328 | A Novel Inherently Radiopaque Bead for Transarterial Embolization to Treat Liver Cancer - A Pre-clinical Study |
| Q90469055 | A Semi-Automated Usability Evaluation Framework for Interactive Image Segmentation Systems |
| Q91106246 | A Study Comparing the Effects of Targeted Intra-Arterial and Systemic Chemotherapy in an Orthotopic Mouse Model of Pancreatic Cancer |
| Q42452852 | A nanoengineered embolic agent for precise radiofrequency ablation |
| Q84953874 | A newly developed double lumen microballoon catheter with a side hole: initial experience of intraarterial infusion chemotherapy and/or embolization |
| Q37092372 | Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma |
| Q28550901 | Alginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of Doxorubicin |
| Q64930199 | Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors. |
| Q39001861 | Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro |
| Q38265114 | Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI. |
| Q100945941 | Automated feature quantification of Lipiodol as imaging biomarker to predict therapeutic efficacy of conventional transarterial chemoembolization of liver cancer |
| Q50276210 | Balloon Blocking Technique (BBT) for Superselective Catheterization of Inaccessible Arteries with Conventional and Modified Techniques |
| Q27010961 | Cancer concepts and principles: primer for the interventional oncologist-part II |
| Q36470428 | Celiac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy. |
| Q38815080 | Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment. |
| Q54937675 | Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma. |
| Q38217457 | Combination of intra-arterial therapies and sorafenib: is there a clinical benefit? |
| Q38908650 | Composition-property relationships for radiopaque composite materials: pre-loaded drug-eluting beads for transarterial chemoembolization |
| Q47095780 | Cure of Hepatoblastoma Through Transcatheter Arterial Chemoembolization |
| Q64941039 | Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer. |
| Q34134852 | Development and preliminary testing of a translational model of hepatocellular carcinoma for MR imaging and interventional oncologic investigations |
| Q35570801 | Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization |
| Q24187663 | Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma |
| Q24202061 | Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinoma |
| Q37669068 | Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes |
| Q40101262 | Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients |
| Q48229554 | Hemodynamic and Anatomic Variations Require an Adaptable Approach during Intra-Arterial Chemotherapy for Intraocular Retinoblastoma: Alternative Routes, Strategies, and Follow-Up. |
| Q38711196 | Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer: efficacy, safety and prognostic parameters. |
| Q36733086 | Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma |
| Q28069290 | Hepatocellular carcinoma: a review |
| Q36171275 | Hepatocellular carcinoma: natural history, current management, and emerging tools |
| Q28087066 | How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer |
| Q35537007 | Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers |
| Q37075313 | Image-guided thermal therapy with a dual-contrast magnetic nanoparticle formulation: A feasibility study |
| Q38117579 | Imaging tumor response following liver-directed intra-arterial therapy. |
| Q37695686 | Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies |
| Q30659636 | Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics. |
| Q38782906 | Intermediate hepatocellular carcinoma: the role of transarterial therapy. |
| Q38792625 | Interventional Oncology in Hepatocellular Carcinoma: Progress Through Innovation |
| Q53038960 | Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinoma. |
| Q47100261 | Liver Metastases in Pancreatic Acinar Cell Carcinoma Treated with Selective Internal Radiation Therapy with Y-90 Resin Microspheres |
| Q88302050 | Locoregional Therapies for the Treatment of Hepatic Metastases from Breast and Gynecologic Cancers |
| Q27015918 | Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy |
| Q47142357 | Long-term survival in a patient with unresectable liver metastases from uveal melanoma treated with transarterial chemoembolization with irinotecan eluting beads - case report and review of literature |
| Q38051041 | MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know |
| Q38745186 | Making the Case: Intra-arterial Therapy for Less Common Metastases. |
| Q36421800 | Microvascular Perfusion Changes following Transarterial Hepatic Tumor Embolization |
| Q37114870 | Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor model |
| Q30443756 | Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research? |
| Q39004808 | Poly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumors |
| Q34652519 | Portal vein embolization: rationale, technique, and current application |
| Q38740839 | Preliminary evaluation of indigenous 90 Y-labelled microspheres for therapy of hepatocellular carcinoma |
| Q51653463 | Preparation of Radiopaque Drug-Eluting Beads for Transcatheter Chemoembolization. |
| Q35761648 | Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study |
| Q85613449 | Radioembolisation for treatment of pediatric hepatocellular carcinoma |
| Q98164567 | Radiopharmaceutical therapy in cancer: clinical advances and challenges |
| Q37253841 | Renal Cell Carcinoma Metastatic to the Liver: Early Response Assessment after Intraarterial Therapy Using 3D Quantitative Tumor Enhancement Analysis |
| Q26851627 | Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma |
| Q49836205 | Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions |
| Q35560995 | Science to practice: Which approaches to combination interventional oncologic therapy hold the greatest promise of obtaining maximal clinical benefit? |
| Q35773556 | Science to practice: what do molecular biologic studies in rodent models add to our understanding of interventional oncologic procedures including percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonists? |
| Q37316201 | Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response? |
| Q40063283 | Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery |
| Q51603728 | Stimulation of apoptotic pathways in liver cancer cells: An alternative perspective on the biocompatibility and the utility of biomedical glasses. |
| Q35672442 | Synthesis and characterization of image-able polyvinyl alcohol microspheres for image-guided chemoembolization |
| Q27007847 | Systematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directions |
| Q36687966 | Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond? |
| Q38209672 | Technical Considerations of Phosphorous-32 Bremsstrahlung SPECT Imaging after Radioembolization of Hepatic Tumors: A Clinical Assessment with a Review of Imaging Parameters |
| Q52628248 | Temperature-sensitive poly(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as an embolic agent: distribution, durability of vascular occlusion, and inflammatory reactions in the renal artery of rabbits. |
| Q34826535 | The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations |
| Q28538311 | Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes |
| Q37716190 | Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography |
| Q38488732 | Transarterial approaches to primary and secondary hepatic malignancies. |
| Q38192781 | Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature |
| Q38531685 | Transarterial chemoembolization (TACE) for colorectal liver metastases--current status and critical review |
| Q37704703 | Transarterial sorafenib chemoembolization: preliminary study of technical feasibility in a rabbit model |
| Q91784365 | Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review |
| Q36689688 | Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer |
| Q90644228 | Treatment Lines in Hepatocellular Carcinoma |
| Q37601096 | Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry. |
| Q28083856 | Yttrium-90 microspheres: a review of its emerging clinical indications |
Search more.